In The News

A blood test that detects tumor DNA in the bloodstream shows promise for identifying colorectal, breast, lung, and ovarian cancers at their earliest, most treatable stages.

Two proof-of-concept studies have found that it may be possible to develop a saliva-based test for Alzheimer disease, perhaps even before symptoms appear.

A recent review of multiple studies concludes that FIT is an accurate screen for colon cancer but not as good at detecting precancerous polyps.

Pancreatic cancer is one of the deadliest types of malignancies. A new blood test could change that by detecting pancreatic cancer in its earliest stages.

ACOG recently published new breast cancer screening guidelines for women with an average risk of breast cancer.

New study suggests type 2 diabetics who are not treated with insulin should not routinely monitor their glucose levels.

CDC issued a health alert on testing for Zika virus infection in asymptomatic pregnant women who live in, travel to areas impacted by Zika.

While consumers can now purchase genetic risk tests for certain diseases without a doctor’s order, they are advised to consult a healthcare professional who can help them understand the implications of their results.

The FDA and CDC warn that results from some blood tests performed on equipment from Magellan Diagnostics LeadCare Testing Systems failed to detect elevated lead levels and recommend that some children and pregnant and nursing mothers be retested for lead poisoning. Photo source: NCI

New draft guidelines from the U.S. Preventive Services Task Force recommend that men between the ages of 55 and 69 make the decision about whether or not to be screened for prostate cancer in consultation with their healthcare practitioner. Photo source: NCI